COLE GILLENWATER: Open Payments
NPI 1932557220 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,138 in 296 payments from 26 companies in 2025. Trend: 2023 $22,547 · 2024 $20,922 · 2025 $8,138
Speaker / faculty: $4,750Food & beverage: $3,388
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $5,108 |
| PFIZER INC. | 60 | $401 |
| AstraZeneca Pharmaceuticals LP | 8 | $378 |
| ABBVIE INC. | 58 | $330 |
| Lilly USA, LLC | 24 | $291 |
| Novo Nordisk Inc | 26 | $233 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $218 |
| Lundbeck LLC | 15 | $156 |
| Amgen Inc. | 22 | $150 |
| Sumitomo Pharma America, Inc. | 10 | $144 |
Products named: AREXVY, XIFAXAN, NURTEC ODT, JARDIANCE, FARXIGA, MOUNJARO, REXULTI, BREZTRI.
Industry payments across KS — which companies pay providers there.
